• Title/Summary/Keyword: formulations

Search Result 1,687, Processing Time 0.032 seconds

Comparing finite element and meshfree particle formulations for projectile penetration into fiber reinforced concrete

  • O'Daniel, James;Adley, Mark;Danielson, Kent;DiPaolo, Beverly;Boone, Nicholas
    • Computers and Concrete
    • /
    • v.7 no.2
    • /
    • pp.103-118
    • /
    • 2010
  • Penetration of a fragment-like projectile into Fiber Reinforced Concrete (FRC) was simulated using finite element (FE) and particle formulations. Extreme deformations and failure of the material during the penetration event were modeled with multiple approaches to evaluate how well each represented the actual physics of the penetration process and compared to experimental data. A Fragment Simulating Projectile(FSP) normally impacting a flat, square plate of FRC was modeled using two target thicknesses to examine the different levels of damage. The thinner plate was perforated by the FSP, while the thicker plate captured the FSP and only allowed penetration part way through the thickness. Full three dimensional simulations were performed, so the capability was present for non-symmetric FRC behavior and possible projectile rotation in all directions. These calculations assessed the ability of the finite element and particle formulations to calculate penetration response while assessing criteria necessary to perform the computations. The numerical code EPIC contains the element and particle formulations, as well as the explicit methodology and constitutive models, needed to perform these simulations.

Encapsulation of an 2-methyl Imidazole Curing Accelerator for the Extended Pot Life of Anisotropic Conductive Pastes (ACPs) (이방 도전성 페이스트의 상온 보관성 향상을 위한 Imidazole 경화 촉매제의 Encapsulation)

  • Kim, Ju-Hyung;Kim, Jun-Ki;Hyun, Chang-Yong;Lee, Jong-Hyun
    • Journal of the Microelectronics and Packaging Society
    • /
    • v.17 no.4
    • /
    • pp.41-48
    • /
    • 2010
  • To improve the pot life of one-part in-house anisotropic conductive paste (ACP) formulations, 2-methyl imidazole curing accelerator powders were encapsulated with five agents. Through measuring the melting point of the five agents using DSC, it was confirmed that a encapsulation process with liquid-state agents is possible. Viscosity of ACP formulations containing the encapsulated imidazole powders was measured as a function of storage time from viscosity measurements. As a result, pot life of the formulations containing imidazole powders encapsulated with stearic acid and carnauba wax was improved, and these formulations indicated similar curing behaviors to a basic formulation containing rare imidazole. However, the bondlines made of these formulations exhibited low average shear strength values of about 37% level in comparison with the basic formulation.

Comparative analysis of herbal formulas in Pharmacopoeia of 4 countries in Northeast Asia (동북아 4개국 약전의 한약제제 비교분석)

  • Jang, Jin-Ho;Lee, Hae-Ni;Kim, Ji-Hoon;Kim, Yun-Kyung
    • The Korea Journal of Herbology
    • /
    • v.30 no.5
    • /
    • pp.75-83
    • /
    • 2015
  • Objectives : The aim of this study was to find how Northeast Asia(Korea, China, Taiwan, Japan) supervise herbal formulas in their pharmacopoeia.Methods : We compared items, formula's effects, formulations, etc and analyzed common formulas among Northeast Asia`s herbal pharmacopoeia (Korea(2010), China(2010), Taiwan(2013), Japan(16th Edition), drugs in Japan OTC Drugs (2007-2008))Results : The Korean Pharmacopoeia, the Korean Herbal Pharmacopoeia, Taiwan herbal pharmacopoeia, the japanese pharmacopoeia, drugs in Japan OTC drugs and pharmacopoeia of the People's Republic of China have 5, 251, 200, 20, 294, 1059 formulas, respectively. In comparison of pharmacopoeia`s test item, Korea and Japan has many similarity, for example, not refer to the effect of formulas. Korea and China have many inspection test of formulations in pharmacopoeia. Each country has differences in ratio of efficacy categories. For example, China especially has a higher ratio of formulas that regulate the blood and Korea has higher ratio of formulas that calm the spirit and open the sensory orifices than those of other 3 countries. There are 17 common formulas among the 4 countries and 43 common formulas among Korea, Taiwan and Japan. Comparing dosage forms, Korea, Japan, Drugs In Japan OTC drugs, Taiwan, China uses 4, 2, 14, 3, 21 formulations, respectively.Conclusions : China has many formulations and new formulas. Taiwan and Japan supervised formulas only selected by the authorities. However, Korean pharmacopoeia has similar form with Japan and need to add more formulas on demand and new formulations.

Efficacy Evaluation of a Leuprorelin Formulation (Lorelin Depot Injection®) by Determination of Serum Testosterone in Rats (혈청 테스토스테론 농도 측정에 의한 로렐린 데포 주사제의 약효 비교 시험)

  • Lee, Hye-Ju;Hwang, Seong-Mee;Shim, Won-Sik;Jung, Goo-Young;Son, Kyung-Chul;Kim, Dae-Duk;Chung, Suk-Jae;Shim, Chang-Koo
    • Journal of Pharmaceutical Investigation
    • /
    • v.39 no.1
    • /
    • pp.37-41
    • /
    • 2009
  • The purpose of this study was to compare the efficacy of Lorelin Depot $Injection^{(R)}$ (Dongkook Pharm. Co., LTD) with Lucrin Depot $Injection^{(R)}$ (Abbott) by measuring serum testosterone level in rats. Leuprorelin (leuprolide acetate), which is an active compound for the two formulations, is an LHRH analogue that is used for the treatment of a wide range of sex hormone-related disorders including advanced prostatic cancer, endometriosis and precocious puberty. Lorelin Depot $Injection^{(R)}$ is a micro-encapsulated formulation to suppress testosterone level by releasing leuprorelin continuously for four weeks with a single subcutaneous injection. The comparison study of the efficacy was performed during four weeks, and serum testosterone levels were monitored in the two formulations. The mean serum testosterone levels from the formulations were decreased to that of the castrate range (50 ng/dL or less) after three days after the initial depot injection, and the concentration were remained throughout four weeks' period. There were no significant differences in the $AUC_{0-3day}$ of testosterone and testosterone levels at 3, 7, 14, 21 and 28 days between the two formulations. These results indicate that the two formulations, Lorelin Depot $Injection^{(R)}$ and Lucrin Depot $Injection^{(R)}$, are bioequivalent in terms of the serum testosterone level in rats.

Effects of Different Mandarin Formulations on Antioxidative Capacity and Oxidative DNA Damage in Fifteen-Month Aged Rats (부위가 다른 감귤의 섭취가 노령흰쥐의 항산화능 및 DNA손상에 미치는 영향)

  • Kim, Ji-Hye;Kwon, Sang-Hee;Kim, Ja-Kyung;Kim, Mi-Kyung
    • Journal of Nutrition and Health
    • /
    • v.39 no.7
    • /
    • pp.610-616
    • /
    • 2006
  • This study was performed to investigate the effect of whole mandarin, peel or pulp intake of Citrus unshiu Marc. on antioxidative capacity and oxidative DNA damage in fifteen-month aged rats. Forty-eight male Sprague-Dawley rats $(621.9\;{\pm}\;10.1\;g)$ were blocked into four groups according to their body weights as control group, whole mandarin powder group, mandarin peel powder group and mandarin pulp powder group. Rats were raised with diets containing 5% (w/w) freeze dried mandarin formulations for four weeks. Total polyphenol content and total antioxidant status (TAS) of mandarin formulations were highest in peel powder, followed by whole powder and then pulp powder. The 8-hydroxy2'-deoxyguanosine concentrations of kidney in all mandarin groups were significantly lower than that of control group, and that of mandarin peel group was much lower than whole powder and pulp groups. Plasma TAS levels of all the experimental groups were higher than that of control group, and among mandarin groups, peel group showed higher level than remaining two groups. In conclusion, all the mandarin formulations were effective on antioxidative capacity in fifteen-month aged rats, and the peel was most effective one among three formulations.

Bioequivalence Evaluation of Senafen Tablet and Airtal Tablet Containing Aceclofenac 100 mg (아세클로페낙(100mg) 제제인 세나펜 정과 에어할 정의 생물학적동등성 평가)

  • 박은우;송우헌;차영주;최영욱
    • Biomolecules & Therapeutics
    • /
    • v.6 no.4
    • /
    • pp.423-428
    • /
    • 1998
  • Aceclofenac is an orally effective non-steroidal anti-inflammatory agent of the phenylacetic acid derivative. Bioequivalence study of two aceclofenac preparations, the test drug (Senafe $n_{R}$: Daewon Phar-maceutical Company) and the reference drug (Airta $l_{R}$: Daewoong Pharmaceutical Company), was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Sixteen healthy male volunteers, 24$\pm$4 years old and 63.9$\pm$6.9 kg of body weight in average, were divided randomly into two groups and administered the drug orally at the dose of 100 mg as aceclofenac in a 2$\times$2 crossover study. Plasma concentrations of aceclofenac were monitored by HPLC method for 12 hr after administration. AU $Co_{-12h}$ (area under the plasma concentration-time curve from initial to 12 hr) was calculated by the linear trapezoidal method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{msx}$) were compiled directly from the plasma drug concentration-time data. Student's t-test indicated no significant differences between the formulations in these parameters. Analysis of variance (ANOVA) revealed that there are no differences in AU $Co_{12h}$, $C_{max}$ and $T_{max}$ between the formulations. The apparent differences between the formulations were far less than 20% (e.g., 0.25, 0.01 and 7.32 for AU $Co_{-12h}$, $C_{max}$. and $T_{max}$, respectively). Minimum detectable differences (%) between the formulations at $\alpha$=0.05 and 1-$\beta$=0.8 were less than 20% (e.g., 14.65, 12.47 and 15.46 for AU $Co_{-l2h}$, $C_{max}$ and $T_{max}$, respectively). The 90% confidence intervals for these parameters were also within $\pm$ 20% (e.g.,-10.19~10.68, -8.87~8.89 and -3.69~ 18.33 for AU $Co_{-12h}$, $C_{msx}$ and $T_{max}$, respectively). These results satisfy the bioequivalence criteria of KFDA guidelines, indicating that two formulations of aceclofenac are bioequivalent.quivalent.ivalent.ent.t.ent.

  • PDF

Relative Bioavailability of Coenzyme Q10 in Emulsion and Liposome Formulations

  • Choi, Chee-Ho;Kim, Si-Hun;Shanmugam, Srinivasan;Baskaran, Rengarajan;Park, Jeong-Sook;Yong, Chul-Soon;Choi, Han-Gon;Yoo, Bong-Kyu;Han, Kun
    • Biomolecules & Therapeutics
    • /
    • v.18 no.1
    • /
    • pp.99-105
    • /
    • 2010
  • The purpose of this study was to evaluate relative bioavailability of the coenzyme Q10 (CoQ10) in emulsion and three liposome formulations after a single oral administration (60 mg/kg) into rats. Emulsion formulation of CoQ10 was prepared by conventional method using Phospholipon 85G as an emulsifier, and three liposome formulations (neutral, anionic, and cationic) of CoQ10 were prepared by traditional lipid film hydration technique using Phospholipon 85G, cholesterol, and charge carrier lipids (1,2-dioleoyl-3-trimethylammonium-propane chloride salt for cationic liposome and 1,2-dimyristoyl-sn-glycero-3-phosphate monosodium salt for anionic liposome). Mean particle size of all CoQ10-loaded liposome was less than a micron, and size distribution of the liposome population was homogeneous. Bioavailability of CoQ10 in emulsion was 1.5 to 2.6-fold greater than liposome formulations in terms of $AUC_{0-24\;h}$. $T_{max}$ was 3 h when administered as emulsion while it was greater than 6 h in liposome formulations. Notably, it was approximately 8 h in cationic liposome. $C_{max}$ was highest in emulsion and was significantly decreased when administered as liposome. Charged liposome showed even lower $C_{max}$ than neutral liposome, especially in cationic liposome. In conclusion, therefore, it is suggested that clinicians and patients consider bioavailability issue a primary concern when choosing a CoQ10 product, especially when very high plasma level is required such as in the treatment of heart failure and Parkinson's disease.

Glass Formulations for Vitrification of Low- and Intermediate-level Waste

  • Kim, Cheon-Woo;Park, Jong-Kil;Ha, Jong-Hyun;Song, Myung-Jae;Lee, Nel-Son;Kong, Peter-C.;Anderson, Gary-L.
    • Journal of the Korean Ceramic Society
    • /
    • v.40 no.10
    • /
    • pp.936-942
    • /
    • 2003
  • In order to develop glass formulations for vitrifying Low-and Intermediate-Level radioactive Wastes (LILW) from nuclear power plants of Korea Hydro & Nuclear Power (KHNP) Co., Ltd., promising glass formulations were selected based on glass property model predictions for viscosity, electrical conductivity and leach resistance. Laboratory measurements were conducted to verify the model predictions. Based on the results, the models for electrical conductivity, US DOE 7-day Product Consistency Test (PCT) elemental release, and pH of PCT leachate are accurate for the LILW glass formulations. However, the model for viscosity was able to provide only qualitative results. A leachate conductivity test was conducted on several samples to estimate glass leach resistance. Test results from the leachate conductivity test were useful for comparison before PCT elemental release results were available. A glass formulation K11A meets all the KHNP glass property constraints, and use of this glass formulation on the pilot scale is recommended. Glass formulations K12A, K12B, and K12E meet nearly all of the processing constraints and may be suitable for additional testing. Based on the comparison between the measured and predicted glass properties, existing glass property models may be used to assist with the LILW glass formulation development.

Factors Influencing the Foliar Uptake of Dimethomorph into Cucumber Induced by Fatty Alcohol Ethoxylate (Fatty Alcohol Ethoxylate에 의해 유도되는 Dimethomorph의 오이 엽면 침투성 영향 인자)

  • Yu, Ju-Hyun
    • The Korean Journal of Pesticide Science
    • /
    • v.12 no.2
    • /
    • pp.118-126
    • /
    • 2008
  • In order to find the best compositions of the dimethomorph formulation containing fatty alcohol ethoxylate surfactants as an activator adjuvant and recommend the good management way of the formulations to allow an intended uptake rate, factors affecting foliar uptake of active ingredients into cucumber were investigated and compared each other. Among tested, the most important factors were air temperature in which plants were located after spraying of aqueous formulations containing activator adjuvant, and deposit of wax on the leaf surface of cucumber. Dimethomorph uptake was found to be increased by sunlight. When aqueous formulations had long-polyethoxylated fatty alcohol surfactants, the relative humidity of the room in which the plants were located after spraying with the formulations did not severely influence the foliar uptake. Maintaining a mild temperature and avoiding too strong sunlight after spraying with dimethomorph formulations were found to be resonable management strategies.

Pharmacokinetics of Two Cyclosporine Formulations Using FPIA and HPLC Assay in Volunterrs

  • Kwon, Kwang-Il;Kim, Moo-Heon;Park, Jong-Woo;Lee, Chang-Hyun
    • Archives of Pharmacal Research
    • /
    • v.18 no.6
    • /
    • pp.385-390
    • /
    • 1995
  • The analytical methods for the analysis of cyclosporine (CsA), a fluorescence polarization immunoassay (FPIA) and HPLC method, were compared in a pharmacokinetic study of two CsA soft capsule formultaions ($Sandimmun^{\circledR}$; Sandoz, $Implanta^{\circledR}$; Hanmi). Sixteen healthy volunteers completed the study and each subjected single doses ($4{\tiems}100$ mg) of the test and the reference formulations in a two-way crossover design with a one-week drug-free interval between doses. Following each administration, whole blood concentrations of CsA were monitored over a period of 24 hour by both FPIA and HPLC methods. Blood concentrations nad pharmacokinetic parameters determined by either analytical method showed large intersubject variation, with the FPIA data showing relatively higher magnitude of intersubjecte variation than the HPLC data. The blood concentrations determined by FPIA were 1.1-1.3 times higher than those determined by HPLC. There were strong and significant correlations between the two methods (r>0.83 : p<0.0001). Intersubuject variation for the $AUC_{inf}{\;}and{\;}AUC_{24hr}$ of the test formulation was slightly reduced without statistical significance (paried -t test : p>0.05 $t_{max}$ was earlier nad $C_{max}$ was slightly lower for the test formulation, $AUC_{24h}, {\;}C_{max}, {\;}T_{max}$ and MRT determined separately from the data obtained by the two methods for the two formulations were examined by analyses of variance (ANOVA) for the bioequivalency evaluation. Results of ANOVA and confidence limits of terst/reference ratios of $AUC_{24th}$, $C_{max}$, $t_{max}$ and MRT, and statistical tests indicated the bioequivalence of the two formulations (i.e., test/reference ratio was within $100{\times}20%$) except for $C_{max}$ and $t_{max}$. The mean of tmax also showed 11.1% and 9.3% differences but the detection limit were 29.2% and 29.6% as determined by FPIA and HPLC resepctively. This experiments suggest that the data yielded for the two formulations demonstrated that they were bioequivalent.

  • PDF